title: Long-term improvement of anaemia in a patient with aplastic anaemia by short-term administration of pegylated recombinant human megakaryocyte growth and development factor.
authors.forename: Akira
authors.initials: A
authors.lastname: Matsuda
authors.forename: Motohiro
authors.initials: M
authors.lastname: Misumi
authors.forename: Maho
authors.initials: M
authors.lastname: Ishikawa
authors.forename: Fumiharu
authors.initials: F
authors.lastname: Yagasaki
authors.forename: Itsuro
authors.initials: I
authors.lastname: Jinnai
authors.forename: Masami
authors.initials: M
authors.lastname: Bessho
authors.forename: Hideaki
authors.initials: H
authors.lastname: Mizoguchi
mesh_terms: D000741:Anemia, Aplastic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013926:Thrombopoietin / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D011994:Recombinant Proteins; C103117:polyethylene glycol-recombinant human megakaryocyte growth and development factor; D011092:Polyethylene Glycols; D013926:Thrombopoietin